Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMPARE: Continuous vs Interrupted Coumadin in AF Ablation
NCT01006876Phase 3Completed
- Sponsor
- Texas Cardiac Arrhythmia Research Foundation
- Start
- Jan 2010
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of warfarin in thromboembolism, sponsored by Texas Cardiac Arrhythmia Research Foundation. Primary endpoint: Absence of thromboembolic events 48 hours post-ablation. Started Jan 2010; status: completed.
02
Drugs
warfarin
03
Conditions
thromboembolism
Beyond the preview
Go deeper on NCT01006876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01006876.